EDGAR Filing Documents for 0001144204-19-015790

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001144204-19-015790

Filing Date

2019-03-25

Accepted

2019-03-25 16:11:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	tv517012_424b3.htm	424B3	474140
	Complete submission text file	0001144204-19-015790.txt		475306

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-227752 | Film No.: 19702778
SIC: 2834 Pharmaceutical Preparations